Ofer Z Fass1, Kamrine E Poels2, Yingzhi Qian3, Hua Zhong3, Peter S Liang4,5. 1. Departments of Medicine. 2. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA. 3. Population Health. 4. Medicine, Division of Gastroenterology and Hepatology, NYU Langone Health. 5. Department of Medicine, VA New York Harbor Health Care System, New York, NY.
Abstract
GOALS: The goal of this study was to quantify the association between demographic factors and advanced colorectal cancer (CRC) in patients under age 50. BACKGROUND: CRC incidence in the United States has declined in older individuals but increased in those under age 50 (early-onset). More than 60% of early-onset CRC patients present with advanced disease (stage III/IV), but predictors of stage in this population are poorly defined. STUDY: We analyzed CRC cases diagnosed between age 20 and 49 in the United States Surveillance, Epidemiology, and End Results (SEER) 18 database during 2004 to 2015. Logistic regression models were fit to assess the impact of age, sex, race, ethnicity, marital status, and cancer site on the probability of advanced disease. RESULTS: The analysis included 37,044 cases. On multivariable regression, age was inversely associated with advanced disease. Relative to 45 to 49-year-olds, 40 to 44-year-olds had 8% greater odds of having advanced CRC, and 20 to 24-year-olds had 53% greater odds. Asians, blacks, and Pacific Islanders had 10%, 12%, and 45% greater odds of advanced disease compared with whites. Compared with nonpartnered individuals, those with partners had 11% lower odds of advanced CRC. Both right-sided and left-sided colon cancer were more likely to be diagnosed at stage IV compared with rectal cancer. CONCLUSIONS: Among individuals with early-onset CRC, younger age, Asian, black, or Pacific Islander race, and being nonpartnered were predictors of advanced disease at presentation. Colon cancer was more likely to be diagnosed at stage IV than rectal cancer. Patient characteristics associated with advanced CRC may indicate both differences in tumor biology and disparities in health care access.
GOALS: The goal of this study was to quantify the association between demographic factors and advanced colorectal cancer (CRC) in patients under age 50. BACKGROUND: CRC incidence in the United States has declined in older individuals but increased in those under age 50 (early-onset). More than 60% of early-onset CRC patients present with advanced disease (stage III/IV), but predictors of stage in this population are poorly defined. STUDY: We analyzed CRC cases diagnosed between age 20 and 49 in the United States Surveillance, Epidemiology, and End Results (SEER) 18 database during 2004 to 2015. Logistic regression models were fit to assess the impact of age, sex, race, ethnicity, marital status, and cancer site on the probability of advanced disease. RESULTS: The analysis included 37,044 cases. On multivariable regression, age was inversely associated with advanced disease. Relative to 45 to 49-year-olds, 40 to 44-year-olds had 8% greater odds of having advanced CRC, and 20 to 24-year-olds had 53% greater odds. Asians, blacks, and Pacific Islanders had 10%, 12%, and 45% greater odds of advanced disease compared with whites. Compared with nonpartnered individuals, those with partners had 11% lower odds of advanced CRC. Both right-sided and left-sided colon cancer were more likely to be diagnosed at stage IV compared with rectal cancer. CONCLUSIONS: Among individuals with early-onset CRC, younger age, Asian, black, or Pacific Islander race, and being nonpartnered were predictors of advanced disease at presentation. Colon cancer was more likely to be diagnosed at stage IV than rectal cancer. Patient characteristics associated with advanced CRC may indicate both differences in tumor biology and disparities in health care access.
Authors: M Jane Park; Tina Paul Mulye; Sally H Adams; Claire D Brindis; Charles E Irwin Journal: J Adolesc Health Date: 2006-07-10 Impact factor: 5.012
Authors: Frank A Sinicrope; Michelle R Mahoney; Harry H Yoon; Thomas C Smyrk; Stephen N Thibodeau; Richard M Goldberg; Garth D Nelson; Daniel J Sargent; Steven R Alberts Journal: Clin Cancer Res Date: 2015-07-17 Impact factor: 12.531
Authors: Xiaocheng Wu; Vivien W Chen; Jim Martin; Steven Roffers; Frank D Groves; Catherine N Correa; Elizabeth Hamilton-Byrd; Ahmedin Jemal Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-07 Impact factor: 4.254
Authors: Saleh Ramezani; Arianna Parkhideh; Pratip K Bhattacharya; Mary C Farach-Carson; Daniel A Harrington Journal: Front Oncol Date: 2021-07-05 Impact factor: 6.244
Authors: Alexi N Archambault; Yi Lin; Jihyoun Jeon; Tabitha A Harrison; D Timothy Bishop; Hermann Brenner; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Jane C Figueiredo; Steven Gallinger; Stephen B Gruber; Marc J Gunter; Michael Hoffmeister; Mark A Jenkins; Temitope O Keku; Loïc Le Marchand; Li Li; Victor Moreno; Polly A Newcomb; Rish Pai; Patrick S Parfrey; Gad Rennert; Lori C Sakoda; Robert S Sandler; Martha L Slattery; Mingyang Song; Aung Ko Win; Michael O Woods; Neil Murphy; Peter T Campbell; Yu-Ru Su; Anne Zeleniuch-Jacquotte; Peter S Liang; Mengmeng Du; Li Hsu; Ulrike Peters; Richard B Hayes Journal: JNCI Cancer Spectr Date: 2021-05-20